Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Bayer Ag Ord (OP:BAYZF)

35.08 +3.16 (+9.90%)
Streaming Delayed Price Updated: 9:30 AM EST, Nov 24, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Bayer Ag Ord

< Previous 1 2 3 Next >
News headline image
Bayer’s Asundexian Met Primary Efficacy and Safety Endpoints in Landmark Phase III OCEANIC-STROKE Study in Secondary Stroke Prevention
From Bayer
Via Business Wire
News headline image
U.S. FDA Approves HYRNUO® (sevabertinib) for Previously Treated Patients with HER2-Mutated Locally Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer
From Bayer
Via Business Wire
News headline image
Agricultural Conglomerate Bayer Confident In Long-Term Outlook Despite Litigation Risks ↗
Bayer's Q3 earnings rose on strong Crop Science and Pharma sales, with CEO Bill Anderson confident in meeting the company's upgraded 2025 guidance. 
Via Benzinga
News headline image
Bayer Launches “Science Delivers” Campaign Celebrating the Transformative Power of Science
From Bayer
Via Business Wire
News headline image
KERENDIA® (finerenone) Meets Primary Endpoint in Phase III Clinical Trial for Adults with Type 1 Diabetes and Chronic Kidney Disease
From Bayer
Via Business Wire
News headline image
Bayer’s Lynkuet® (elinzanetant), the First and Only Neurokinin 1 and Neurokinin 3 Receptor Antagonist, Receives FDA Approval for Moderate to Severe Hot Flashes Due to Menopause
From Bayer
Via Business Wire
News headline image
Late-breaking data from Phase III OCEANIC-STROKE study accepted for presentation at World Stroke Congress 2025
From Bayer
Via Business Wire
News headline image
Bayer Partners with Cornfed Farms to Create First ForwardFarm in Midwest
From Bayer
Via Business Wire
News headline image
One A Day® Unveils Bold New Brand Identity and Platform: “The ONE for you”
From Bayer
Via Business Wire
News headline image
BlueRock Therapeutics reports positive 36-month results from Phase I trial of bemdaneprocel for treating Parkinson’s disease
From Bayer
Via Business Wire
News headline image
Bayer Selects Interpublic as Global Media, Production and Creative Agency Partner for Consumer Health Division
From Bayer
Via Business Wire
News headline image
Bayer to Highlight New Data for KERENDIA® (finerenone) at Heart Failure Society of America (HFSA) Annual Scientific Meeting 2025
From Bayer
Via Business Wire
News headline image
Bayer First Company to Advance Cell Therapy as Well as Gene Therapy Against Parkinson’s Disease
From Bayer
Via Business Wire
News headline image
10 Years of Supporting Rural America: Bayer and Luke Bryan Team Up with Feeding America® to Tackle Hunger with “Take Care, Now” Campaign
From Bayer
Via Business Wire
News headline image
Gadoquatrane New Drug Application Accepted for Review by U.S. FDA
From Bayer
Via Business Wire
News headline image
Monsanto Reaches Agreements in Principle to Resolve Additional PCB Cases at the Sky Valley Education Center
From Bayer
Via Business Wire
News headline image
Bayer® Aspirin Introduces Aspirina to the U.S. Pain Market
From Bayer
Via Business Wire
News headline image
OTC Markets Group Welcomes Bayer AG to OTCQX
From OTC Markets
Via GlobeNewswire
News headline image
Bayer Shares Fall 7% As US Court Reconsiders Monsanto PCB Exposure Case ↗
German life sciences giant Bayer saw its shares drop by over 7% on Wednesday following a US court’s decision to review a case against Monsanto, a subsidiary acquired by Bayer in 2018. 
Via Talk Markets
News headline image
Futures Rally Fizzles As Dollar, Yields And Oil Slump ↗
US equity futures erased earlier gains and were trading with modest losses as the dollar, oil, and yields all slumped entering the US session. 
Via Talk Markets
News headline image
Bayer Weedkiller Lawsuit Dismissed By Australian Judge: Insufficient Evidence Linking Roundup To Blood Cancer ↗
Australian judge dismisses class action lawsuit against Bayer for Roundup causing cancer. Ruling supports company's stance that product is safe. 
Via Benzinga
Topics Lawsuit
News headline image
Judge Slashes Bayer's Massive $2B Roundup Verdict To $400M ↗
Pennsylvania judge cuts Bayer's $2.25 billion Roundup verdict to $400 million. Both Bayer and plaintiff plan appeals in the ongoing cancer litigation. 
Via Benzinga
News headline image
After UnitedHealth Cyberattack, Drug Distributor Cencora Notifies Americans' Health Information Stolen In Data Breach In February ↗
Cencora reports a cyberattack exposing sensitive medical information, including patient names, addresses, birth dates, diagnoses, and medications. 
Via Benzinga
Topics Data Breach
News headline image
Bayer Highlights Detailed Data From Twin Late-Stage Trials On Experimental Menopause Candidate, Seeks Regulatory Approval ↗
Bayer to present detailed Phase 3 OASIS 1 and 2 study results showing elinzanetant significantly reduces moderate to severe menopausal vasomotor symptoms compared to placebo. 
Via Benzinga
News headline image
Bayer's Monsanto Scores Legal Victory as $185M Verdict Overturned ↗
Bayer's Monsanto unit secures a significant legal victory as Washington state appeals court overturns $185 million verdict over chemical contamination. This highlights broader legal battles over PCBs... 
Via Benzinga
News headline image
Bayer's Third Menopausal Relief Drug Trial Meets Primary Goal, German Conglomerate Seeks FDA Approval For Elinzanetant ↗
Bayer's Phase 3 study OASIS 3 findings on elinzanetant, a promising non-hormonal treatment for menopausal hot flashes. Results show significant reduction in symptoms over 12 weeks, marking a potential... 
Via Benzinga
News headline image
German Conglomerate Bayer Goes Johnson & Johnson Way To Tackle Its Cancer Related Lawsuits ↗
Bayer contemplates Texas Two-Step bankruptcy to tackle Roundup lawsuits in the US amid mounting jury verdicts. Learn about the controversial tactic and its potential implications. 
Via Benzinga
Topics Bankruptcy Lawsuit
News headline image
Bayer Holds Splitting Into Separate Units For Three Years, Focus Shifts On Tackling Challenges ↗
Bayer charts strategic course amid structural evaluation. CEO Bill Anderson addresses group's challenges, prioritizing performance and flexibility. The company's focus and fiscal outlook for 2024. 
Via Benzinga
News headline image
What's Going On With BridgeBio Pharma Stock On Monday? ↗
BridgeBio Pharma partners with Bayer on acoramidis for ATTR-CM in Europe. $310 million deal, FDA application accepted. 
Via Benzinga
News headline image
Weedkiller Woes: Australian Court Nears Decision in Bayer's Roundup Trial ↗
Follow the landmark Australian Roundup lawsuit against Bayer. Closing arguments in class action alleging Roundup's link to cancer. 
Via Benzinga
Topics Lawsuit
< Previous 1 2 3 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.